Compare Chart Industries Inc (GTLS) vs Zoetis Inc (ZTS) Price & Performance

GTLS trades at $209.97, up 0.03% on the day, with a bullish technical outlook supported by moving averages but overbought RSI signals. The company reported $4.26B in 2025 revenue but missed earnings estimates for three consecutive quarters, with a negative net income margin of -0.62%. Recent news highlights Baker Hughes' pending $13.6B acquisition, which received conditional EU approval in July 2026, potentially driving investor optimism.

The stock's outlook is mixed: strong analyst buy consensus (54%) and acquisition prospects offer upside, but weak profitability and earnings misses pose risks. Investors should weigh the acquisition's completion against fundamental challenges like negative ROE and high P/E of 629.67, indicating premium valuation despite profitability concerns.

Zoetis (ZTS) trades at $77.13, up 4.12% in the last session, with a bearish technical signal from moving averages. The company reported strong 2025 results, including $9.47B revenue and $2.67B net income, with high profitability margins. Recent news highlights a securities class action lawsuit and the launch of Lenivia in Canada and the EU. Cash flow improved to a positive $325M in 2025, though net cash flow is projected to decline in 2026.

The stock presents a mixed outlook: strong fundamentals and a consensus price target of $101.43 suggest upside, but legal risks and bearish technicals pose near-term headwinds. Earnings momentum is key, with Q2 2026 results critical after a Q1 miss. Institutional sentiment is cautious despite no sell ratings.